...
首页> 外文期刊>Healthcare. >Enabling provider decision-making that improves quality and costs in oncology: An interview with Andrew Norden from Cota Healthcare
【24h】

Enabling provider decision-making that improves quality and costs in oncology: An interview with Andrew Norden from Cota Healthcare

机译:使提供者决策可以提高肿瘤内的质量和成本:从Cota Healthcare采访Andrew Norden

获取原文
获取原文并翻译 | 示例
           

摘要

Andrew Norden is the Chief Medical Officer of Cota Healthcare. Cota's mission is to enable the optimization of clinical outcomes for individual patients and to reduce the total cost of care for populations. Prior to Cota, he served as Deputy Chief Health Officer of IBM Watson Health, Attending Neuro-Oncologist at the Dana-Farber Cancer Institute, and Assistant Professor of Neurology at Harvard Medical School. He holds an MD from Yale School of Medicine, an MPH from the Harvard School of Public Health, and an MBA from the University of Massachusetts at Amherst.
机译:安德鲁·诺登是Cota Healthcare的首席医学官。 科拉的使命是为了优化个别患者的临床结果,并降低人口的总照顾成本。 在科托之前,他曾担任IBM Watson Health的副主席,参加Dana-Farber癌症研究所的神经肿瘤科学家,以及哈佛医学院神经内科的助理教授。 他拥有来自耶鲁医学院的MD,来自哈佛大学公共卫生,以及阿默斯塔特大学的MBA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号